Global Cardiac Event Monitor, MCT Monitor, and Implantable Event Monitor Market Shares, Strategies, and Forecasts, 2017-2023

Dublin, May 08, 2017 -- Research and Markets has announced the addition of Wintergreen Research, Inc's new report "Cardiac Event Monitor, MCT Monitor, and Implantable Event Monitor: Market Shares, Strategies, and Forecasts, 2017 to 2023" to their offering.

Consideration of cardiac event recorder forecasts indicate that markets at $1.1 billion in 2016 will reach $4.8 billion by 2023.

Cardiac event monitor market forecasts, event recorder device, MCT device, and implantable recorders are charged for as services when the units are provided to patients in this manner. Insurance reimbursement is many times a more favorable way to collect money from a service. The implantable segment of the overall cardiac event recording market goes from 58% of the total to 80% of the total. It implantable devices are far more reliable and accurate than the electronic external devices.

Growth is based on implementation of devices that measure cardiac function over a period of a month, provide analytics within the device, and send alerts to a physician. Growth is based on implementation of devices that measure cardiac function over a period of a month, provide analytics within the device, and send alerts to a physician.

Growth comes as this technology is able to support the greater emphasis that is being put on early diagnosis and prevention of disease by the medical community as a whole. Heart disease has been the number one killer of people, creating a need for more proactive and ongoing diagnosis made possible by increased use of the remote units extending medical care from the acute care setting to everyday modalities.

Digitalization of healthcare is shifting value from devices per se to software and services. Physicians are looking for new ways to proactively monitor and manage patient health. The challenges of delivering patient cardiac care can only be met through new, more integrated forms of care delivery across the health continuum, with a shift away from a focus on acute care and late-stage interventions to continuing care delivery that is appropriate to the circumstance.

Disruptive technologies, disruptive services offerings change cardiac event recorder markets, clinicians are leveraging technology to save lives.

Key Topics Covered:

1. Cardiac Event Monitoring
2. Postacute Care Co-ordination
3. Healthcare Reform Readmission
4. High Risk Heart Failure Patient
5. CHF
6. Congestive Heart Failure
7. Diabetes Treatment
8. Cardiac Event Recording
9. HIPAA Privacy and Security
10. Telemonitoring
11. Tele-monitoring
12. Cardiac Event Recorder
13. Cardiac Event Monitor
14. Implantable Event Monitor
15. Mobile Cardiac Telemetry MCT Monitor

Companies Mentioned

Market Leaders:

• Biotelemetry
• Cardionet
• eCardio Applied Cardiac Systems
• Mednet Preventice Solutions

Selected Market Participants:

• AliveCor
• Applied Cardiac Systems
• AT&T
• Biomedical Systems
• BioTelemetry
• Biotronik
• CardGuard Lifewatch / CardGuard
• General Electric (GE)
• iRhythm / Zio
• LifeLine Medical
• Medicomp
• Medtronic
• Nuvasive
• OSI Systems
• Philips
• Preventice Solutions
• QRS Diagnostic
• Reka
• Samsung
• Scott Fetzer
• VivaLnk
• VRI
• Windstream

For more information about this report visit http://www.researchandmarkets.com/research/4l8xs4/cardiac_event

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: Cardiovascular Devices